Duros® leuprolide implant for continuous one-year treatment of prostate cancer

Proceedings of the Controlled Release Society

Volumn , Issue 25, 1998, Pages 516-517

  Wright, J ^a   Chen, G ^a   Cukierski, M ^a   Davis, C ^a   Falender, C ^a   Mabanglo, D ^a   Peery, J ^a   Ponnekanti, L ^a   Skowronski, R ^a   Stevenson, C ^a   Tao, S ^a   Brown, J ^a  

^a ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUPRORELIN; TESTOSTERONE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG IMPLANT; DRUG RELEASE; DRUG STABILITY; NONHUMAN; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

EID: 0031869139     PISSN: 10220178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)